Chemotherapy in the Older Patient with Operable Non-Small Cell Lung Cancer: Neoadjuvant and Adjuvant Regimens

Ilene Browner, Michael Purtell

Research output: Contribution to journalReview articlepeer-review

Abstract

Several excellent, non-age-specific review articles and meta-analyses summarize in detail the available trials of surgery and either induction or adjuvant therapy with or without local radiotherapy in the treatment of early non-small cell lung cancer (NSCLC). A detailed review of the literature on the comprehensive assessment of and chemotherapy in the elderly patient with NSCLC is beyond the scope of this article. Instead, the goal is to amalgamate the two topics and develop some practical guidelines to assist the clinician in deciding which therapies most are appropriate for older patients with potentially curable NSCLC.

Original languageEnglish (US)
Pages (from-to)377-389
Number of pages13
JournalThoracic surgery clinics
Volume19
Issue number3
DOIs
StatePublished - Aug 1 2009

Keywords

  • Adjuvant chemotherapy
  • Elderly
  • Neoadjuvant chemotherapy
  • Non-small cell lung cancer
  • Operable

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Chemotherapy in the Older Patient with Operable Non-Small Cell Lung Cancer: Neoadjuvant and Adjuvant Regimens'. Together they form a unique fingerprint.

Cite this